Frequency of application of topical corticosteroids: An overview

British Journal of Dermatology

Volumn 139, Issue 5, 1998, Pages 763-766

  Lagos, B R ^a   Maibach, H I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; HALCINONIDE; HYDROCORTISONE BUTYRATE; LOCOID LIPOCREAM; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; CLINICAL RESEARCH; DOSE CALCULATION; DRUG EFFICACY; DRUG SCREENING; ECZEMA; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; PRIORITY JOURNAL; PSORIASIS; REVIEW; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; DRUG ADMINISTRATION SCHEDULE; GLUCOCORTICOIDS; HUMANS; SKIN DISEASES;

EID: 0031774635     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02498.x     Document Type: Review

References (21)

1. Sudilovsky A, Muir JG, Bocobo FC. Topical corticosteroids the need (?) for frequent applications, Int J Dermatol 1981; 20: 594-6.
2. Rogers R. Frequency of application of topical corticosteroids. (Letter.) Int J Dermatol 1981; 20: 616.
3. Vickers CHF. Existence of reservoir in the stratum corneum. Arch Dermatol 1963; 88: 72-5.
4. Feldmann RJ, Maibach HI. Penetration of 14C-hydrocortisone through normal skin: The effect of stripping and occlusion. Arch Dermatol 1965; 91: 661-6.
5. Wester RC, Noonan PK, Maibach HI. Frequency of application of percutaneous absorption of hydrocortisone. Arch Dermatol 1977; 113: 620-2.
6. du Vivier A, Stoughton RB. Tachyphylaxis to the action of topically applied corticosteroids. Arch Dermatol 1975; 111: 581-3.
7. du Vivier A. Tachyphylaxis to topically applied steroids. Arch Dermatol 1976; 112: 1245-8.
8. Barry BW, Woodford R. Vasoconstrictor activities and bioavail-abilities of seven proprietary corticosteroid creams assessed using a non-occlused multiple dosage regimen: clinical implication. Br J Dermatol 1977; 97: 555-60.
9. Hehir M, du Vivier A, Eilon L et al. Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment. Clin Exp Derm 1983; 8: 143-51.
10. Pierard GE, Pierard-Franchimont C, Ben Mosbah T et al. Adverse effects of topical corticosteroids. Acta Derm Venereol (Stockh) 1989; 69: 26-30.
11. Turpeinen M. Absorption of hydrocortisone from the skin reservoir in atopic dermatitis. Br J Dermatol 1991; 124: 358-60.
12. Turpeinen M, Salo OP, Leisti S, Effect of percutaneous absortion of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. Br J Dermatol 1986; 115: 475-84.
13. Turpeinen M, Lehtokoski-Lehtiniemi E, Leisti S et al. Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children. Pediatr Dermatol 1988; 5: 276-9.
14. Aalto-Korte K, Turpeinen M. Pharmacokinetics of topical hydrocortisone at plasma level after application once or twice daily in patients with widespread dermatitis. Br J Dermatol 1995; 133: 259-6.
15. Gartner L, Tarras-Wahlberg C. A double-blind controlled evaluation of Diproderm cream 0.05% twice a day treatment in comparison with once a day treatment in eczema. J Int Med Res 1984; 12: 59-61.
16. English JS, Bunker CB, Ruthven K. A double blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses. Clin Exp Dermatol 1989; 14: 32-4.
17. Singh S, Gopal J, Mishra RN. Topical 0.05% betamethasone dipropionate: efficacy in psoriasis with once a day vs. twice a day application. Br J Dermatol 1995; 133: 497-8.
18. Koopman B, Lasthein Andersen B, Mork NJ et al. Multicentre randomized double-blind study of Locoid lipocream fatty cream twice daily versus Locoid lipocream once daily and locobase once daily. J Dermatol Treatment 1995; 6: 103-6.
19. Tharp M. Comparison of twice daily and once daily administration of fluticasone propionate cream 0.05% in the treatment of eczema. Cutis 1996; 57: 19-26.
20. Fredriksson T, Lassus A, Bleeker J. Treatment of psoriasis and atopic dermatitis with halocinonide cream applied once and three times daily. Br J Dermatol 1980; 102: 575-7.
21. Sudilovsky A, Muir JG, Bocobo FC. A comparison of single and multiple applications of halcinonide cream. Int J Dermatol 1981; 20: 609-13.